The density, size, and location of tumor infiltrating macrophages in prostate cancer have been showed as powerful predictors of patient outcome, and prostate cancer specimens' harbor increased positive cells expressing the macrophage specific marker CD68 compared to benign glands [92–94]. The gene discussed is CD68; the disease is prostate cancer.